(Q54705026)

English

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Selim Firat

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

Roger W Byhardt

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

Elizabeth Gore

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

54

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

357-364

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbidity and functional status are independent in older cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical-severity staging system for oropharyngeal cancer: five-year survival rates

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New clinical severity staging system for cancer of the larynx. Five-year survival rates

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical-severity staging system for patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of comorbidity on 3-year survival of women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cumulative illness rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring comorbidity in older cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902939-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(02)02939-5

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/12243808

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54705026&oldid=2050718272"